Andreas David Lauritzen (@andefader) profile picture

PostDoc in @MLSectionUCPH at @Uni_Copenhagen and @RegionH. Improving breast cancer screening with AI.

Copenhagen, Denmark
Joined September 2013
Andreas David Lauritzen retweeted
Implementation of AI reduced the workload of breast radiologists and improved screening performance in a regional Danish population-based breast cancer screening program. @RegionH @MLSectionUCPH @uni_copenhagen @andefader bit.ly/3yK3O2D
1
1
2
4,789
With contributions from first author Andreas Lauritzen from @MLSectionUCPH. Congratulations to the team!
A model combining AI lesion detection and mammographic texture improved performance of mammography-based risk assessment in a screening cohort of Danish women. @andefader @uni_copenhagen @MLSectionUCPH bit.ly/3R0bJQi
2
4
389
Andreas David Lauritzen retweeted
I did an interview on our #PACAP #migraine paper - go check it out!
This Post is from an account that no longer exists. Learn more
1
4
14
Andreas David Lauritzen retweeted
AI-based screening was able to detect normal, moderate-risk, and suspicious mammograms in a breast cancer screening program, which may reduce the radiologist workload. @andefader @MLSectionUCPH @screenpointmed @AiCentreDK bit.ly/3JQeCMd
2
12
Andreas David Lauritzen retweeted
Regionsrådet i @RegionH bevilger 15 mio. kr. til kræftområdet - ventetiden skal ned på screening for brystkræft og kræftpakkeforløb. #sundpol regionh.dk/presse-og-nyt/pre…
2
1
10
Andreas David Lauritzen retweeted
#breakingnews - the largest #breast #AI study published in Radiology shows value of Transpara in mammographic screening. Read the full release here. prnewswire.com/news-releases… #breastcancer #artificialintelligence #radiology #pacs #breastcancerawareness #healthcare
5
4
Andreas David Lauritzen retweeted
Vores løsning med mønstergenkendelse i mammografiscreeninger er ved OffDig blevet hædret med Publikumsprisen bit.ly/3II599m #cancer #digitalisering #sundpol #dkpol #dkmedier @Offdig1
1
6
Andreas David Lauritzen retweeted
Ernstsen et al. show that PACAP-38 provokes migraine-like changes independently of CGRP, suggesting that PACAP-38 antagonism could be an alternative therapeutic approach for patients unresponsive to CGRP-targeting therapies. bit.ly/3ou7lK7
7
2
18